Creo Medical Group PLC
LSE:CREO
Creo Medical Group PLC
Operating Expenses
Creo Medical Group PLC
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Creo Medical Group PLC
LSE:CREO
|
Operating Expenses
-£43.9m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Smith & Nephew PLC
LSE:SN
|
Operating Expenses
-$3.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
LivaNova PLC
NASDAQ:LIVN
|
Operating Expenses
-$714.8m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-16%
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Operating Expenses
-$286.1m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Operating Expenses
-£19.5m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
Angle PLC
LSE:AGL
|
Operating Expenses
-£25.6m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Creo Medical Group PLC's Operating Expenses?
Operating Expenses
-43.9m
GBP
Based on the financial report for Dec 31, 2022, Creo Medical Group PLC's Operating Expenses amounts to -43.9m GBP.
What is Creo Medical Group PLC's Operating Expenses growth rate?
Operating Expenses CAGR 3Y
-32%
Over the last year, the Operating Expenses growth was -6%. The average annual Operating Expenses growth rates for Creo Medical Group PLC have been -32% over the past three years .